Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma
Andy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Molecular Therapy. Oncology
|
September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models
Christopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Transplantation and Cellular Therapy
|
June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
Neela Easton, Mia Andreoli, Herman van Besien, et al.
Cancer Discovery
|
February 1, 2015
The genetics of splicing in neuroblastoma
Justin Chen, Christopher S Hackett, Shile Zhang, et al.
Cell Reports
|
May 29, 2026
Tumor-intrinsic expression of signal regulatory protein α contributes to the suppression of anti-tumor immune responses
Chien-Huan Weng, Chana Schochet, Vincent Panneton, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit
Fei Yi, Tal Cohen, Natalie Zimmerman, et al.
Cancer Research
|
October 22, 2009
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality
Lara S Collier, David J Adams, Christopher S Hackett, et al.
Nature Medicine
|
September 28, 2010
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
Alexander Swarbrick, Susan L Woods, Alexander Shaw, et al.
Genes & Development
|
August 3, 2012
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics
Xi Huang, Adrian M Dubuc, Rintaro Hashizume, et al.
Nature Cancer
|
July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit
Fei Yi, Tal Cohen, Natalie Zimmerman, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
European Journal of Cancer (Oxford, England : 1990)
|
April 24, 2007
Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma
Andy J Cheng, Ngan Ching Cheng, Jette Ford, et al.
Molecular Therapy. Oncology
|
September 23, 2024
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models
Christopher S Hackett, Daniel Hirschhorn, Meixian S Tang, et al.
Transplantation and Cellular Therapy
|
June 17, 2026
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
Neela Easton, Mia Andreoli, Herman van Besien, et al.
Cancer Discovery
|
February 1, 2015
The genetics of splicing in neuroblastoma
Justin Chen, Christopher S Hackett, Shile Zhang, et al.
Cell Reports
|
May 29, 2026
Tumor-intrinsic expression of signal regulatory protein α contributes to the suppression of anti-tumor immune responses
Chien-Huan Weng, Chana Schochet, Vincent Panneton, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit
Fei Yi, Tal Cohen, Natalie Zimmerman, et al.
Cancer Research
|
October 22, 2009
Whole-body sleeping beauty mutagenesis can cause penetrant leukemia/lymphoma and rare high-grade glioma without associated embryonic lethality
Lara S Collier, David J Adams, Christopher S Hackett, et al.
Nature Medicine
|
September 28, 2010
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
Alexander Swarbrick, Susan L Woods, Alexander Shaw, et al.
Genes & Development
|
August 3, 2012
Voltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamics
Xi Huang, Adrian M Dubuc, Rintaro Hashizume, et al.
Nature Cancer
|
July 22, 2025
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit
Fei Yi, Tal Cohen, Natalie Zimmerman, et al.
Page
of 3